Cargando…
Nimotuzumab with intensity-modulated radiation therapy in unresectable and platinum-ineligible locally advanced head-and-neck cancer
BACKGROUND: Outcomes with conventional treatment are poor in patients with squamous cell carcinoma of head and neck (SCCHN). Treatment options are further limited for patients ineligible to receive platinum-based chemotherapy due to various factors such as geriatric age, comorbidity, and organ dysfu...
Autores principales: | Srinivas, K. Satish, Sundaram, Raja, Divyambika, C. V., Chaudhari, Sameer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956585/ https://www.ncbi.nlm.nih.gov/pubmed/31956621 http://dx.doi.org/10.4103/sajc.sajc_29_19 |
Ejemplares similares
-
Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: A hospital-based retrospective evidence
por: Subramanian, Sundaram, et al.
Publicado: (2018) -
Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: An Indian rural hospital experience
por: Rawat, Shyamji, et al.
Publicado: (2019) -
Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence
por: Subramanian, Sundaram, et al.
Publicado: (2019) -
Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: Prospective comparative study - ESCORT-N study
por: Kumar, Ashok, et al.
Publicado: (2019) -
Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation
por: Lazarev, Stanislav, et al.
Publicado: (2017)